Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
BJU International|July 30, 2014
Should we routinely stent after ureteropyeloscopy?Darren Foreman, Sophie Plagakis, Andrew T FullerJournal of Endourology Case Reports|September 1, 2016
Transperitoneal Robot-Assisted Radical Prostatectomy Should Be Considered in Prostate Cancer Patients with Pelvic KidneysSophie Plagakis, Darren Foreman, Peter Sutherland, et al.Lower Urinary Tract Symptoms|August 14, 2019
The autologous pubovaginal fascial sling: An update in 2019Sophie Plagakis, Vincent TseFrontiers in Neuroscience|January 23, 2024
BCG induced lower urinary tract symptoms during treatment for NMIBC-Mechanisms and management strategiesGeorgia Bourlotos, William Baigent, Matthew Hong, et al.Neurourology and Urodynamics|September 10, 2016
Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatmentNathan Hoag, Sophie Plagakis, Samantha Pillay, et al.BMC Urology|September 30, 2023
Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancerGiorgio Gandaglia, Riccardo Leni, Sophie Plagakis, et al.BJU International|February 19, 2016
Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mLMann Ang, Branimir Rajcic, Darren Foreman, et al.International Urology and Nephrology|December 1, 2017
Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?Richard Hoffmann, Callum Logan, Michael O'Callaghan, et al.Clinical Case Reports|May 27, 2024
Elevation of the tumor marker CA19-9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case reportSteve D Pendry, Nimit Singhal, Eu-Ling Neo, et al.Cancer Epidemiology|March 11, 2020
Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013Jake Tempo, Callum Logan, Michael O'Callaghan, et al.Pageof 2